We are pleased to announce that of the ten Contractors that successfully completed Phase 2, eight have now been awarded Specific Contracts for Phase 3 to complete testing and integration of the innovative NGS workflows.
Phase 3 commenced in April 2024 and will end in May 2025.
Further details can be found under Phase 3 – Testing and Integration
Selected Contractors:
Lot 1: Pre-Sequencing
Trinity- Project abstract
Lead: QIAGEN GmbH
TwistPlatomicsMGI – Project abstract
Lead: Twist Bioscience Corporation
Lot 3: Bioinformatics Analysis
Congenica L3 – Project abstract
Lead: Congenica Limited BIC Wellcome Genome Campus
Consortium members: Single tenderer
Consortium members: Single tenderer
Cancer Analysis GPAP – Project abstract
Lead: FUNDACIO CENTRE DE REGULACIO GENOMICA
Consortium members: Single tenderer
Consortium members: Single tenderer
PlatoDKFZCharité – Project abstract
Lead: Platomics GmbH
Consortium members: Deutsches Krebforschungszentrum, Charité Universitätsmedizin Berlin
Consortium members: Deutsches Krebforschungszentrum, Charité Universitätsmedizin Berlin
Lot 4: Integrated Reporting
Cancer Reporting GPAP – Project abstract
Lead: FUNDACIO CENTRE DE REGULACIO GENOMICA
Consortium members: Single tenderer
Congenica L4 – Project abstract
Lead: Congenica Limited BIC Wellcome Genome Campus
Consortium members: Single tenderer
Consortium members: Single tenderer
EU Onco Platform L4 – Project abstract
Lead: BC Platforms AG
Consortium members: Euformatics Oy, Oncompass Medicine Hangary Kft.
